Takashi Kawahara

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 8

Top Topics

Peritoneal Dialysis

Chronic Kidney Disease

Top Venues

International journal of urology : official journal of the Japanese Urological Association

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Yuki Kita, Hikari Otsuka, Katsuhiro Ito, Takuto Hara, Soichiro Shimura, Takashi Kawahara, Minoru Kato, Sojun Kanamaru, Koji Inoue, Hiroki Ito, Atsushi Igarashi, Tomokazu Sazuka, Dai Takamatsu, Kohei Hashimoto, Takashige Abe, Sei Naito, Yoshiyuki Matsui, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi, null null
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association (2024)
Yuki Kita, Hikari Otsuka, Katsuhiro Ito, Takuto Hara, Soichiro Shimura, Takashi Kawahara, Minoru Kato, Sojun Kanamaru, Koji Inoue, Hiroki Ito, Atsushi Igarashi, Tomokazu Sazuka, Dai Takamatsu, Kohei Hashimoto, Takashige Abe, Sei Naito, Yoshiyuki Matsui, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi, null null
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Yuki Kita, Hikari Otsuka, Katsuhiro Ito, Takuto Hara, Soichiro Shimura, Takashi Kawahara, Minoru Kato, Sojun Kanamaru, Koji Inoue, Hiroki Ito, Atsushi Igarashi, Tomokazu Sazuka, Dai Takamatsu, Kohei Hashimoto, Takashige Abe, Sei Naito, Yoshiyuki Matsui, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi, null null
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Yuki Kita, Hikari Otsuka, Katsuhiro Ito, Takuto Hara, Soichiro Shimura, Takashi Kawahara, Minoru Kato, Sojun Kanamaru, Koji Inoue, Hiroki Ito, Atsushi Igarashi, Tomokazu Sazuka, Dai Takamatsu, Kohei Hashimoto, Takashige Abe, Sei Naito, Yoshiyuki Matsui, Hiroyuki Nishiyama, Hiroshi Kitamura, Takashi Kobayashi, null null
Real-world sequential treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in Japan. International journal of urology : official journal of the Japanese Urological Association 31 (5) (2024)
Hiroyuki Nishiyama, Junji Yonese, Takashi Kawahara, Ryuji Matsumoto, Hideaki Miyake, Nobuaki Matsubara, Hiroji Uemura, Masatoshi Eto, Haruhito Azuma, Wataru Obara, Akito Terai, Satoshi Fukasawa, Shigetaka Suekane
TAS0313 Plus Pembrolizumab for Post-Chemotherapy Immune Checkpoint Inhibitor-Naïve Locally Advanced or Metastatic Urothelial Carcinoma. Molecular cancer therapeutics (2023)
Hikari Otsuka, Yuki Kita, Katsuhiro Ito, Takeshi Sano, Junichi Inokuchi, Ryotaro Tomida, Atsushi Takahashi, Kazumasa Matsumoto, Ryoma Kurahashi, Yu Ozaki, Masayuki Uegaki, Satoru Maruyama, Shoichiro Mukai, Masakazu Tsutsumi, Takashi Kawahara, Takehiko Segawa, Hiroshi Kitamura, Satoshi Morita, Takashi Kobayashi
Immune-related adverse events in urothelial cancer patients: Adjustment for immortal time bias. Cancer science 113 (11) (2022)
Takashi Kawahara, Koji Kawai, Takahiro Kojima, Yoshiyuki Nagumo, Shotarou Sakka, Syuya Kandori, Hiromitsu Negoro, Bryan J Mathis, Kazushi Maruo, Koji Miura, Noriaki Sakamoto, Nobuo Shinohara, Shinichi Yamashita, Kan Yonemori, Takeshi Kishida, Osamu Ukimura, Kazuo Nishimura, Yasuyuki Kobayashi, Hiroyuki Nishiyama
Phase II trial of nivolumab monotherapy and biomarker screening in patients with chemo-refractory germ cell tumors. International journal of urology : official journal of the Japanese Urological Association 29 (7) (2022)
Takashi Kawahara, Takahiro Kojima, Shuya Kandori, Masahiro Kurobe, Takayuki Yoshino, Tomokazu Kimura, Yoshiyuki Nagumo, Ryutaro Ishituka, Koji Mitsuzuka, Shintaro Narita, Takashi Kobayashi, Yoshiyuki Matsui, Osamu Ogawa, Mikio Sugimoto, Jun Miyazaki, Hiroyuki Nishiyama
TP53 codon 72 polymorphism is associated with FGFR3 and RAS mutation in non-muscle-invasive bladder cancer. PloS one 14 (8) (2019)